The FDA has issued a warning letter to Regenerative Processing Plant after conducting an inspection of the facility. The plant manufactures two ophthalmic drug products, Regener-Eyes Professional Ophthalmic Solution and Regener-Eyes LITE Ophthalmic Solution.
FDA issues warning to ophthalmic drug producer
